Goldenwell BiotechGWLL 30 Interest Coverage is 0 (At Loss) as of Mar. 2026. GuruFocus rates GWLL with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 1,511 Consumer Packaged Goods companies, Goldenwell Biotech ranks worse than 66181.27% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Goldenwell Biotech's
Operating Income
for the
three
months ended in Mar. 2026 was $-0.03 Mil. Goldenwell Biotech's Interest Expense for the
three
months ended in Mar. 2026 was $-0.00 Mil.
did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Goldenwell Biotech's Interest Coverage or its related term are showing as below:
GWLL's Interest Coverage is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 8.61 * Ranked among companies with meaningful Interest Coverage only.
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Goldenwell Biotech Interest Coverage Related Terms
Goldenwell Biotech Interest Coverage Historical Data
* Premium members only.
The historical data trend for Goldenwell Biotech's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
GWLL vs HAIN, LSF, BFNH: Interest Coverage Comparison
For the Packaged Foods subindustry, Goldenwell Biotech's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Goldenwell Biotech Interest Coverage vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Goldenwell Biotech's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Goldenwell Biotech's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Goldenwell Biotech did not have earnings to cover the interest expense.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of 0 (At Loss) mean?
Goldenwell Biotech (GWLL) has a Interest Coverage of 0 (At Loss) as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Goldenwell Biotech and its competitors. According to the industry distribution chart, Goldenwell Biotech ranks #999999 out of 1511 companies in the Consumer Packaged Goods industry.
Is Goldenwell Biotech's Interest Coverage too high?
Goldenwell Biotech's current Interest Coverage is 0 (At Loss). Based on the distribution chart, Goldenwell Biotech ranks #999999 out of 1511 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Goldenwell Biotech has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Goldenwell Biotech's Interest Coverage compare to HAIN and LSF?
According to the Consumer Packaged Goods industry distribution chart, Goldenwell Biotech ranks #999999 out of 1511 companies for Interest Coverage. This places Goldenwell Biotech in the lower half of its industry. The industry median Interest Coverage is 8.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Consumer Packaged Goods company?
The median Interest Coverage among Consumer Packaged Goods companies is 8.61, based on 1,511 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Goldenwell Biotech and its competitors. For the Consumer Packaged Goods industry, the median Interest Coverage is 8.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Goldenwell Biotech's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Goldenwell Biotech stock overvalued right now?
Goldenwell Biotech (GWLL) has a current Interest Coverage of 0 (At Loss). The current Interest Coverage is 0 (At Loss). Goldenwell Biotech's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Goldenwell Biotech (GWLL), the current Interest Coverage is 0 (At Loss) as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Goldenwell Biotech Inc is engaged in the research and development, production, and sales of healthcare and supplement products. Its products comprise JI MAI - Bovine Cardiac Vascular Active Peptide, Double Proline AG - 3D Active Collagen Peptide, Cartilage Peptide - Type II collagen peptide, and Sugar Master.
30GF Score
Get the complete analysis for GWLL
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GWLL has been successfully added to your 
